
Onconic presents positive P3 data for Jaqbo at DDW 2025
Onconic Therapeutics said unveiled encouraging phase 3 clinical trial results for Jaqbo (ingredient: zastaprazan citrate) in gastric ulcer patients at the 2025 Digestive Disease Week (DDW) held in San Diego, California, from May 3 to 6. DDW, the world’s …